StockWatch
·
Biotechnology: Pharmaceutical Preparations
BuybackJul 15, 2026, 06:11 AM

Lakefront Repurchases 108,645 Shares for €2.9M

AI Summary

Lakefront Biotherapeutics announced the repurchase of 108,645 of its own shares between July 6 and July 10, 2026, as part of a previously announced program. The shares were acquired at an average price of €26.67, totaling €2,897,722.65. Following these transactions, Lakefront Biotherapeutics holds 412,401 of its own ordinary shares as of July 10, 2026.

Key Highlights

  • Lakefront Biotherapeutics repurchased 108,645 shares.
  • The buyback occurred between July 6, 2026, and July 10, 2026.
  • The average price paid per share was €26.67.
  • The total value of the repurchased shares was €2,897,722.65.
  • As of July 10, 2026, the company holds 412,401 of its own ordinary shares.